These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8787923)

  • 41. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Chong H; Zhu Y; Yu D; He Y
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.
    De Clercq E; Yamamoto N; Pauwels R; Balzarini J; Witvrouw M; De Vreese K; Debyser Z; Rosenwirth B; Peichl P; Datema R
    Antimicrob Agents Chemother; 1994 Apr; 38(4):668-74. PubMed ID: 7913308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.
    Clanton DJ; Buckheit RW; Terpening SJ; Kiser R; Mongelli N; Borgia AL; Schultz R; Narayanan V; Bader JP; Rice WG
    Antiviral Res; 1995 Aug; 27(4):335-54. PubMed ID: 8540754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine.
    Ikeda R; Haraguchi Y; Ikeda Y; Kondo S; Takeuchi T; Hoshino H
    Antiviral Res; 1996 Mar; 29(2-3):163-73. PubMed ID: 8739596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolism and mode of selective inhibition of human immunodeficiency virus replication by 3'-azido-2',3'-dideoxy-5-iodouridine and 3'-azido-2',3'-dideoxy-5-bromouridine.
    August EM; Qian HY; Birks EM; Thombre UA; Lin TS; Prusoff WH
    Biochem Pharmacol; 1993 Jan; 45(1):223-30. PubMed ID: 7678740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-angiogenesis agent DS-4152 is a potent and selective inhibitor of HIV-1 replication in vitro.
    Baba M; Shigeta S; Ikeuchi T; Korenaga H; Osada Y
    AIDS; 1994 Jan; 8(1):43-8. PubMed ID: 7516666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
    Steinkasserer A; Harrison R; Billich A; Hammerschmid F; Werner G; Wolff B; Peichl P; Palfi G; Schnitzel W; Mlynar E
    J Virol; 1995 Feb; 69(2):814-24. PubMed ID: 7815548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro antiviral activity of polyoxomolybdates. Mechanism of inhibitory effect of PM-104 (NH4)12H2(Eu4(MoO4)(H2O)16(Mo7O24)4).13H2O on human immunodeficiency virus type 1.
    Inouye Y; Tokutake Y; Yoshida T; Seto Y; Hujita H; Dan K; Yamamoto A; Nishiya S; Yamase T; Nakamura S
    Antiviral Res; 1993 Apr; 20(4):317-31. PubMed ID: 8387260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Inhibition of human immunodeficiency virus replication by anionic dyes].
    Iakubov LA; Pliasunova OA; Fediuk NV; Pokrovskiĭ AG; Vlasov VV
    Dokl Akad Nauk; 1996 Apr; 347(5):696-8. PubMed ID: 8744361
    [No Abstract]   [Full Text] [Related]  

  • 52. Antiviral properties of palinavir, a potent inhibitor of the human immunodeficiency virus type 1 protease.
    Lamarre D; Croteau G; Wardrop E; Bourgon L; Thibeault D; Clouette C; Vaillancourt M; Cohen E; Pargellis C; Yoakim C; Anderson PC
    Antimicrob Agents Chemother; 1997 May; 41(5):965-71. PubMed ID: 9145853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro assessment of compounds for anti-HIV activity.
    Patience C; Moore J; Boyd M
    Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
    Mohan P; Schols D; Baba M; De Clercq E
    Antiviral Res; 1992 Jun; 18(2):139-50. PubMed ID: 1384428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.
    Yang H; Li X; Yang X; Lu P; Wang Y; Jiang Z; Pan H; Zhao L; Zhu Y; Khan IU; Shen Y; Lu H; Zhang T; Jiang G; Ma Z; Wu H; Zhu H
    Antiviral Res; 2019 Sep; 169():104555. PubMed ID: 31295520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective inhibition of human immunodeficiency virus type 1 replication by novel fluoroalkylated oligomers in vitro.
    Baba M; Kira T; Shigeta S; Matsumoto T; Sawada H
    J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):24-30. PubMed ID: 8263750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
    Okruszek A; Olesiak M; Balzarini J
    J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems.
    Balzarini J; Aquaro S; Perno CF; Witvrouw M; Holý A; De Clercq E
    Biochem Biophys Res Commun; 1996 Feb; 219(2):337-41. PubMed ID: 8604988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.
    Taylor DL; Brennan TM; Bridges CG; Mullins MJ; Tyms AS; Jackson R; Cardin AD
    Antiviral Res; 1995 Oct; 28(2):159-73. PubMed ID: 8585769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1.
    Moog C; Wick A; Le Ber P; Kirn A; Aubertin AM
    Antiviral Res; 1994 Aug; 24(4):275-88. PubMed ID: 7993073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.